Personalised care and personal health budget programme: learning and next steps

13 June 2018

A report from charity National Voices describes the role that the voluntary, community and social enterprise sector has to play in delivering personalised care, and shows what needs to happen at a local level to realise this potential. It sets out how personal health budgets are enabling people to make new choices and share responsibility for their own health and wellbeing, while helping them to be active citizens.

 

Latest News

Child death review: statutory and operational guidance

17 October 2018

This guidance sets out the full process that follows the death of a child who is normally resident in England. It builds on existing statutory requirements and clarifies how individual professionals and organisations across all sectors should contribute to child death reviews.

Read More

NHS England urged to develop children’s health strategy

17 October 2018

A report by the Royal College of Paediatrics and Child Health (RCPCH) compares health outcomes of children and young people in England compared with other wealthy European and western countries. It uses historical data and modelling techniques to project likely outcomes in 2030, and recommends that NHS England develops a strategy for children and young people’s health.

Read More

New tool to make it easier for health professionals to talk about physical activity

17 October 2018

The Moving Medicine tool will help healthcare professionals advise patients on how physical activity can help to manage their conditions, prevent disease and aid recovery.

It is produced by the Faculty of Sport and Exercise Medicine (FSEM) in partnership with Public Health England (PHE) and Sport England with National Lottery funding.

The tool is aimed particularly at those with the most common long term health conditions, such as cancer, depression, musculoskeletal pain and type 2 diabetes.

Read More

Price fall of ‘most costly drug’ set to save the NHS £150m a year

17 October 2018

NHS hospitals stand to save £150m a year as the NHS’s most costly drug becomes cheaper.

Adalimumab is the single medicine on which hospitals spend the most, at a cost of more than £400 million a year. As the patent has now expired, most patients can now expect to be treated with a much cheaper ‘biosimilar’.

At least 80% of existing patients should be switched to the best value equivalent within 12 months, NHS England has told CCGs and trusts.

Read More

Why caring for the people who care matters

16 October 2018

NHS England has produced infographics for commissioners to use to highlight the importance of looking after carers.

Read More